215 related articles for article (PubMed ID: 15213572)
21. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
Pogány K; Zaaijer HL; Prins JM; Wit FW; Lange JM; Beld MG
AIDS Res Hum Retroviruses; 2005 Nov; 21(11):922-6. PubMed ID: 16386107
[TBL] [Abstract][Full Text] [Related]
22. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
[TBL] [Abstract][Full Text] [Related]
23. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
[TBL] [Abstract][Full Text] [Related]
25. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
26. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B: Prevalence and occult infection in HIV-infected patients.
Calux SJ; Silva VCM; Compri AP; Lemos MF; Santos APT; Oba IT; Mendes-Correa MCJ; Moreira RC
Rev Soc Bras Med Trop; 2020; 53():e20180533. PubMed ID: 31994654
[TBL] [Abstract][Full Text] [Related]
29. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.
Bell TG; Makondo E; Martinson NA; Kramvis A
PLoS One; 2012; 7(10):e45750. PubMed ID: 23049685
[TBL] [Abstract][Full Text] [Related]
31. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V
J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
34. Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study.
Palacios R; Mata R; Hidalgo A; Muñoz L; Viciana I; Del Arco A; López-Cortés LF; Peña A; de la Torre J; Santos J;
HIV Clin Trials; 2008; 9(5):337-40. PubMed ID: 18977722
[TBL] [Abstract][Full Text] [Related]
35. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
36. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
Amponsah-Dacosta E; Selabe SG; Mphahlele MJ
J Med Virol; 2018 Feb; 90(2):291-303. PubMed ID: 28971485
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
Salia E; Nartey YA; Djankpa FT; Pappoe F; Nuvor SV; Obiri-Yeboah D
PLoS One; 2024; 19(6):e0305862. PubMed ID: 38924017
[TBL] [Abstract][Full Text] [Related]
39. Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India.
Panigrahi R; Majumder S; Gooptu M; Biswas A; Datta S; Chandra PK; Banerjee A; Chakrabarti S; Bandopadhyay D; De BK; Chakravarty R
Ann Hepatol; 2012; 11(6):870-5. PubMed ID: 23109450
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
